AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in AEON Biopharma, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2025
- Shares held
- 2.44M
- +1.08M (+79.0%) vs. Q3 2025
- Total value
- $1.67M
- +$563.9K (+51.1%) vs. Q3 2025
- New holders
- 4
- 8 more added
- Sold out
- 3
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $9.22M |
| Q1 2026 | 24 | $2.80M |
| Q4 2025 | 22 | $1.67M |
| Q3 2025 | 21 | $1.10M |
| Q2 2025 | 18 | $585.7K |
| Q1 2025 | 16 | $884.8K |
| Q4 2024 | 37 | $4.80M |
| Q3 2024 | 30 | $10.1M |
| Q2 2024 | 25 | $8.73M |
| Q1 2024 | 27 | $103.5M |
| Q4 2023 | 20 | $56.8M |
| Q3 2023 | 16 | $29.3M |
| Q2 2023 | 17 | $12.0M |
| Q1 2023 | 21 | $19.6M |
| Q4 2022 | 86 | $248.3M |
| Q3 2022 | 81 | $226.5M |
| Q2 2022 | 73 | $213.1M |
| Q1 2022 | 71 | $202.3M |
| Q4 2021 | 73 | $192.0M |
| Q3 2021 | 59 | $171.8M |
| Q2 2021 | 47 | $126.0M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding AEON Biopharma, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 2,131,852 | $1.32M | 4.87% | +1,006,852+89.5% | Added |
| Vanguard Group Inc | 100,333 | $110.4K | 0.00% | +1,765+1.8% | Added |
| Geode Capital Management, LLC | 60,134 | $66.1K | 0.00% | +13,061+27.7% | Added |
| XTX Topco Ltd | 56,852 | $62.5K | 0.00% | +40,690+251.8% | Added |
| Blue Owl Capital Holdings LP | 43,395 | $47.7K | 0.01% | +1,042+2.5% | Added |
| Laird Norton Trust Company, LLC | 15,000 | $16.5K | 0.00% | +15,000 | New |
| Two Sigma Securities, LLC | 13,180 | $14.5K | 0.00% | +13,180 | New |
| Citadel Advisors LLC | 11,642 | $12.8K | 0.00% | +11,642 | New |
| UBS Group AG | 4,052 | $4.46K | 0.00% | +2,860+239.9% | Added |
| BlackRock, Inc. | 2,834 | $3.12K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,382 | $2.62K | 0.00% | +6+0.3% | Added |
| Wolff Wiese Magana LLC | 567 | $624 | 0.00% | +500+746.3% | Added |
| DuPont Capital Management Corp | 170 | $187 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 150 | $165 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 105 | $116 | 0.00% | −1−0.9% | Reduced |
| Steward Partners Investment Advisory, LLC | 100 | $110 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 95 | $105 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 90 | $99 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 58 | $64 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 33 | $36 | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 4 | $4 | 0.00% | +4 | New |
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 0 | $0 | 0.00% | −17,578−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,420−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |